Wolverine Trading’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.22M Buy
12,434
+3,726
+43% +$398K ﹤0.01% 2693
2025
Q2
$929K Sell
8,708
-2,123
-20% -$214K ﹤0.01% 2379
2025
Q1
$1.03M Buy
10,831
+5,766
+114% +$646K ﹤0.01% 2208
2024
Q4
$570K Sell
5,065
-7,463
-60% -$852K ﹤0.01% 3250
2024
Q3
$1.48M Buy
12,528
+1,227
+11% +$113K ﹤0.01% 1977
2024
Q2
$908K Buy
11,301
+8,242
+269% +$753K ﹤0.01% 2279
2024
Q1
$282K Sell
3,059
-1,446
-32% -$139K ﹤0.01% 3424
2023
Q4
$475K Sell
4,505
-581
-11% -$58.5K ﹤0.01% 3009
2023
Q3
$553K Buy
+5,086
New +$563K ﹤0.01% 2679
2023
Q1
Sell
-12,043
Closed -$1.81M 4244
2022
Q4
$1.81M Buy
12,043
+1,945
+19% +$299K ﹤0.01% 1453
2022
Q3
$1.35M Sell
10,098
-10,979
-52% -$1.68M ﹤0.01% 1714
2022
Q2
$2.99M Sell
21,077
-1,961
-9% -$300K 0.01% 1086
2022
Q1
$4.03M Buy
+23,038
New +$3.87M 0.01% 1212
2021
Q3
Sell
-22,321
Closed -$7.09M 6270
2021
Q2
$5.09M Buy
22,321
+13,018
+140% +$2.46M 0.01% 1127
2021
Q1
$972K Buy
9,303
+3,296
+55% +$350K ﹤0.01% 2799
2020
Q4
$504K Buy
+6,007
New +$590K ﹤0.01% 3166

Other funds holding BNTX

Wolverine Trading's BNTX Position: Q3 2025 in Review

Wolverine Trading increased its BioNTech (BNTX) stake by 43% in Q3 2025, buying an estimated $398K and bringing the position to 12,434 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2693.

Wolverine Trading first reported a position in BNTX in Q4 2020 and has held it in 16 quarters since. The position peaked at $5.09M in Q2 2021. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

  • Wolverine Trading held 12,434 shares of BioNTech worth $1.22M as of Q3 2025.
  • Wolverine Trading bought 3,726 BioNTech shares in Q3 2025, an estimated $398K.
  • BioNTech made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2693 holding.
  • Wolverine Trading first reported a position in BioNTech in Q4 2020 and has held it in 16 quarters since.
  • Wolverine Trading's BioNTech position peaked at $5.09M in Q2 2021.
  • 254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.